These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16649027

  • 1. Vitamin D intoxication and therapy with alendronate (case report and review of literature).
    Orbak Z, Doneray H, Keskin F, Turgut A, Alp H, Karakelleoglu C.
    Eur J Pediatr; 2006 Aug; 165(8):583-4. PubMed ID: 16649027
    [No Abstract] [Full Text] [Related]

  • 2. Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method.
    Doneray H, Ozkan B, Caner I, Ozkan A, Karakelleoglu C.
    Clin Toxicol (Phila); 2008 Apr; 46(4):300-2. PubMed ID: 18363123
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
    Demir K, Döneray H, Kara C, Atay Z, Çetinkaya S, Çayır A, Anık A, Eren E, Uçaktürk A, Can Yılmaz G, Törel Ergür A, Kendirci M, Aycan Z, Bereket A, Aydın M, Orbak Z, Özkan B.
    J Clin Res Pediatr Endocrinol; 2019 May 28; 11(2):140-148. PubMed ID: 30396880
    [Abstract] [Full Text] [Related]

  • 4. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis.
    Atabek ME, Pirgon O, Sert A.
    J Pediatr Endocrinol Metab; 2006 Feb 28; 19(2):169-72. PubMed ID: 16562591
    [Abstract] [Full Text] [Related]

  • 5. Use of alendronate in the treatment of vitamin D intoxication in infants.
    Hatun S, Cizmecioğlu F.
    Turk J Pediatr; 2005 Feb 28; 47(4):373-5. PubMed ID: 16363349
    [Abstract] [Full Text] [Related]

  • 6. Oral bisphosphonate therapy for vitamin D intoxication of the infant.
    Bereket A, Erdogan T.
    Pediatrics; 2003 Apr 28; 111(4 Pt 1):899-901. PubMed ID: 12671131
    [Abstract] [Full Text] [Related]

  • 7. Comparison of oral alendronate versus prednisolone in treatment of infants with vitamin D intoxication.
    Sezer RG, Guran T, Paketçi C, Seren LP, Bozaykut A, Bereket A.
    Acta Paediatr; 2012 Mar 28; 101(3):e122-5. PubMed ID: 22004010
    [Abstract] [Full Text] [Related]

  • 8. Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.
    Chatterjee M, Speiser PW.
    J Pediatr Endocrinol Metab; 2007 Nov 28; 20(11):1241-8. PubMed ID: 18183797
    [Abstract] [Full Text] [Related]

  • 9. Severe hypercalcaemia in a child secondary to use of alternative therapies.
    Boyd C, Moodambail A.
    BMJ Case Rep; 2016 Oct 06; 2016():. PubMed ID: 27758796
    [Abstract] [Full Text] [Related]

  • 10. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD, Farahmand P, Schacht E, Rozehnal A.
    Rheumatol Int; 2007 Mar 06; 27(5):425-34. PubMed ID: 17216477
    [Abstract] [Full Text] [Related]

  • 11. Use of vitamin D drops leading to kidney failure in a 54-year-old man.
    Auguste BL, Avila-Casado C, Bargman JM.
    CMAJ; 2019 Apr 08; 191(14):E390-E394. PubMed ID: 30962197
    [No Abstract] [Full Text] [Related]

  • 12. Effects of alendronate and calcifediol compared to alendronate and cholecalciferol in osteoporotic patients.
    Giampà E, Di Bonito M, Ferretti V, Nuvoli G, Paoletti F, Piazzini M, Ranieri M, Tuveri MA, Vinicola V.
    Minerva Endocrinol; 2019 Dec 08; 44(4):344-350. PubMed ID: 31971357
    [Abstract] [Full Text] [Related]

  • 13. [Alendronate and resorptive hypercalciuria].
    Arrabal-Polo MA, Arrabal-Martin M, Zuluaga-Gomez A.
    Med Clin (Barc); 2011 Sep 17; 137(7):333. PubMed ID: 21543092
    [No Abstract] [Full Text] [Related]

  • 14. Multiple renal calculi due to hypercalcaemia induced by over-the-counter vitamin D intoxication.
    Manappallil RG, Shylendran S, Kakkattil A, Thomas AD.
    BMJ Case Rep; 2018 Aug 20; 2018():. PubMed ID: 30131404
    [Abstract] [Full Text] [Related]

  • 15. An infant with hypercalcemia: questions.
    Guarino S, Marzuillo P, Apicella A, Annicchiarico Petruzzelli L, La Manna A.
    Pediatr Nephrol; 2014 Nov 20; 29(11):2121. PubMed ID: 24141524
    [No Abstract] [Full Text] [Related]

  • 16. Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy.
    Apkon S, Coll J.
    Am J Phys Med Rehabil; 2008 Feb 20; 87(2):139-43. PubMed ID: 17912140
    [Abstract] [Full Text] [Related]

  • 17. Risks of the 'Sunshine pill' - a case of hypervitaminosis D.
    Ellis S, Tsiopanis G, Lad T.
    Clin Med (Lond); 2018 Aug 20; 18(4):311-313. PubMed ID: 30072556
    [Abstract] [Full Text] [Related]

  • 18. Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.
    Gilfraguas L, Guadalix S, Martinez G, Jodar E, Vara J, Gomez-Sanchez MA, Delgado J, De La Cruz J, Lora D, Hawkins F.
    Prog Transplant; 2012 Sep 20; 22(3):237-43. PubMed ID: 22951500
    [Abstract] [Full Text] [Related]

  • 19. Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
    Antoniucci DM, Sellmeyer DE, Bilezikian JP, Palermo L, Ensrud KE, Greenspan SL, Black DM.
    J Clin Endocrinol Metab; 2007 Mar 20; 92(3):942-7. PubMed ID: 17164314
    [Abstract] [Full Text] [Related]

  • 20. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.